The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 28, 2026 for Aayush Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aayush Agrawal, acting as trustee of the Aayush Agrawal Trust, has disclosed the release of pledge on 1,92,500 shares (0.15% of total share capital) of Ajanta Pharma Limited. The pledge release was executed on 22-May-2026 and the reason cited is loan repaid. Post the release, the trust continues to hold 1,41,12,924 shares representing 11.30% of the company's total share capital. Of this holding, 87,81,662 shares (7.03%) remain encumbered (pledged) as collateral.
The release of pledge indicates that a portion of the promoter group's shares have been freed from encumbrance due to loan repayment. This is generally viewed as a positive development as it reduces debt burden and improves the flexibility of promoter holdings. However, the significant portion of shares (7.03%) still under pledge warrants monitoring.